Serum levels of insulin-like growth factor (IGF) and IGF-binding protein in constitutionally short children and adolescents

Publisher Website
Google Scholar
Abstract
Serum insulin-like growth factor (IGF) and IGF-binding protein (IGF-bp) levels were studied in 92 constitutionally short children and adolescents (height < mean for age-2 SD) and in 13 subjects after completion of growth. IGF levels increased with age in a manner similar to that in normal subjects, but at lower levels (P < 0.001). The values were 0.41 .+-. 0.03 SEM U/ml in 1 to 5 year old children, 0.72 .+-. 0.03 U/ml in 6- to 16 year old prepubescent children and 0.95 .+-. 0.05 U/ml during puberty. IGF-bp levels developed in a similar way, the values being 0.45 .+-. 0.06, 0.61 .+-. 0.04 and 0.85 .+-. 0.06 U/ml, respectively, for the three periods considered. Both IGF and IGF-bp levels in each of the three groups were significantly lower than those in normal subjects at the same stage of development. After fusion of the epiphyses, IGF and IGF-bp levels were within the normal range. A longitudinal study was undertaken in 15 subjects, showing increases in height corresponding with increases in IGF levels. For all the subjects studied during their growth period, there was a correlation between height age and IGF levels (r= 0.64, P < 0.001). All the subjects exhibited a normal rise in GH levels following stimulation. Although the possibility of quantitative or qualitative disorders of GH biosynthesis cannot be excluded in some of the cases, our data are comparable with the hypothesis that the growth retardation observed in constitutionally short children results, at least in part, from insufficient IGF production during post-natal growth.